Evaluating the diagnostic performance of [18F]ALF-NOTA-FAPI-04 PET/CT in gastric cancer: a comparative study with [18F]FDG PET/CT
Question Early diagnosis and precise staging of gastric cancer are crucial for patient prognosis; however, current imaging techniques still face significant limitations. Findings [<sup>18</sup>F]ALF-NOTA-FAPI-04 PET/CT demonstrated significantly higher sensitivity than [<sup>18</sup>F]FDG PET/CT in detecting primary or recurrent tumors and metastases in patients with gastric cancer. Clinical relevance [<sup>18</sup>F]ALF-NOTA-FAPI-04 PET/CT is an advanced imaging diagnostic technique that significantly enhances the diagnostic accuracy for gastric cancer and its metastatic lesions. This technology provides robust support for clinical decision-making, thereby improving the management of patients with gastric cancer.
Authors
- Chengzhi Jiang (ORCID: https://orcid.org/0000-0002-9196-9858)
- Jing-Hui Lv (ORCID: https://orcid.org/0000-0003-0656-8222)
- Kai Zheng (ORCID: https://orcid.org/0000-0002-3488-4946)
- Xiang Peng (ORCID: https://orcid.org/0000-0002-3237-7916)
- Jian Yang (ORCID: https://orcid.org/0000-0001-8170-0727)
- Yanyin Zhang (ORCID: https://orcid.org/0009-0008-5804-4344)
- Hui Ye
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
Publication Details
- Journal
- European Radiology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1007/s00330-024-11219-z
- Citations
- 3
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Wu Jieping Medical Foundation